What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Vikran Engineering (NSE: VIKRAN) Q3 FY26 results show solar-led order book surge as margins reset during execution ramp-up
Ducon Infratechnologies (NSE: DUCON) Q3 FY26 results signal margin pressure even as carbon capture and AI bets move closer to execution
Read More 5 minute read Healthcare Industry News Can bioresorbable drug‑eluting scaffolds solve the compliance problem in chronic sinus care? Can bioresorbable nasal implants like ARIS and PROPEL improve compliance in chronic sinus care? Explore how this growing tech is reshaping ENT drug delivery. byPallavi MadhirajuSeptember 8, 2025